Company profilePharmaceutical#724 of 1,318 in Pakistan✓ No DRAP alerts

RG PHARMA

Pharmaceutical company · 13 brands · 16 molecules

Ranked #37 of 156 companies in Antianemic, Iron Preparations

13 registered products 13 pharmaceutical brands 16 distinct molecules 0 DRAP alerts

Company overview

13
registered products
13
pharmaceutical brands
16
distinct molecules
12
therapeutic classes
0
DRAP alerts

RG PHARMA is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 13 product registrations across 16 distinct molecules. Its portfolio is concentrated in Antianemic, Iron Preparations and Blood Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by RG

14 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Calcium Channel Blockers 2
Antiemetics & Antinauseants 2
Antianemic, Iron Preparations 2
Gonadotropins And Other Ovulation Stimulants 2
All Other Therapeutic Products, Antidotes 1

Top molecules by brand count

Iron Sucrose2 brands
Metolazone1 brand
Sevelamer1 brand
Recombinant Human Erythropoietin ...... 2000 Iu1 brand
Recombinant Human Erythropoietin ...... 10000 Iu1 brand

Therapeutic classes

Antianemic, Iron Preparations · 3Blood Conditions · 1Progestogen · 1Hormone Regulators · 1Diuretic · 1All Other Therapeutic Products, Antidotes · 1Gastro · 1Bile And Liver Therapy · 1Calcium Channel Blockers · 1Drugs For Treatment Of Hyperkalemia And Hyperphosphatemia · 1Other Antianemic Preparations (Erythropoietin Products) · 1Antiemetics & Antinauseants · 1

Conditions treated

Anaemia · 1Hormonal Therapy · 1Probiotic · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official3 products · Rs 2,077.7 – Rs 6,057.76
DVAGO4 products · Rs 1,121 – Rs 6,650
Servaid4 products · Rs 877.5 – Rs 1,832
Median across source: Rs 3,500

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

AJ Mirza Pharma Pvt Ltd DSL: 235 holds 18 molecules not in this portfolio
AtorvastatinBovine Lipid Extract SurfactantCapecitabineEntecavirErlotinibFlutamide
Martin Dow Pharmaceuticals (Pvt) Ltd. holds 143 molecules not in this portfolio
AlfacalcidolAmlodipineApixabanArtemetherAspirinAzithromycin
MARTIN DOW PHARMACEUTICALS (PAK) LTD. holds 9 molecules not in this portfolio
AmlodipineBudesonideCyanocobalaminNicotinamideRiboflavinThiamine

Get the full profile for RG

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.